image
Mobile_image
eyebrow
For adults with relapsed systemic anaplastic large cell lymphoma
headline
Unlock your next step
content
ADCETRIS is approved to treat adults with relapsed systemic anaplastic large cell lymphoma (sALCL) after at least 1 combination chemotherapy treatment fails.
Learn more about the benefits and risks of ADCETRIS and see how people responded in a clinical study.
Learn more about the benefits and risks of ADCETRIS and see how people responded in a clinical study.
buttons
headline
About systemic anaplastic large cell lymphoma
content
T-cell lymphoma is a type of blood cancer that makes up less than 15% of non-Hodgkin lymphomas. They start in early forms of white blood cells called T cells. Peripheral T-cell lymphomas (PTCLs) specifically are uncommon types of lymphoma that develop from more mature forms of T cells.
Systemic ALCL is a fast-growing type of T-cell lymphoma. It may appear in the skin, lymph nodes, bones, soft tissues, lungs, or liver. Anaplastic large cell lymphomas comprise about 1% of all non-Hodgkin lymphomas and about 10% to 20% of all T-cell lymphomas.
Systemic ALCL is a fast-growing type of T-cell lymphoma. It may appear in the skin, lymph nodes, bones, soft tissues, lungs, or liver. Anaplastic large cell lymphomas comprise about 1% of all non-Hodgkin lymphomas and about 10% to 20% of all T-cell lymphomas.
image
Mobile_image
headline
ADCETRIS is a well-established treatment backed by over a decade of clinical data
content
- Nearly 1700 patients with certain types of lymphoma received treatment with ADCETRIS across 8 clinical trials
- Over 67,000 patients in the US and over 183,000 patients worldwide have been treated with ADCETRIS since 2011
Healthcare providers have relied on the extensive clinical study data of ADCETRIS when treating their patients. Researchers continue to investigate ADCETRIS in clinical trials today.
headline
Talk to your doctor about ADCETRIS
content
Communicating openly with your doctor is an important part of making sure that your treatment is right for you. Your appointment is an opportunity to share symptoms, ask questions, and discuss your treatment goals. These resources are designed to help you feel confident and prepared to have those conversations with your healthcare provider.
icon
headline
ADCETRIS patient brochure
icon
headline
Doctor Discussion Guide
content
It's important to ask questions and share concerns about ADCETRIS treatment with a doctor. The Doctor Discussion Guide can help you navigate the conversation, so you get the most out of your visit. Take this printable PDF with you to your next appointment.
headline
Glossary
content
Relapse: When cancer has returned after signs and symptoms of cancer had reduced or became undetectable.
Systemic anaplastic large cell lymphoma (sALCL): A fast-growing type of T-cell lymphoma. It may appear in the skin, lymph nodes, bones, soft tissues, lungs, or liver.